Mortalin-MPD (mevalonate pyrophosphate decarboxylase) interactions and their role in control of cellular proliferation.

Mortalin (mot-2/GRP75/PBP74/mthsp70) is a member of the hsp70 family of proteins and is differentially distributed in normal and immortal cells. It was shown to be involved in pathways to cell senescence and immortalization. To elucidate its functional aspects, a yeast interactive screen for mortalin (mot-2) binding proteins was performed. Mevalonate pyrophosphate decarboxylase (MPD) was identified as one of the mortalin binding partners. The interactions were confirmed in mammalian cells by two-hybrid assay and in vivo coimmunoprecipitation. MPD is known to furnish prenyl groups required for prenylation, protein modification that is essential for the activity of many proteins including p21(Ras) (Ras). We have examined the effect of MPD-mot-2 interactions on the level and activity of p21(Ras) and its downstream effectors, p44 and p42 MAP kinases (ERK1/ERK2), in Ras-Raf pathway. An overexpression of mot-2 resulted in reduced level of Ras and phosphorylated ERK2. These were rescued by co-expression of MPD from an exogenous promoter demonstrating a functional link between mot-2, MPD, and Ras. Ras and its oncogenic forms act as key players in controlling proliferation of normal and cancerous cells. Assigning mot-2 upstream of p21(Ras) offers an important mechanism for influence over cell proliferation.

[1]  Y. Yamori,et al.  Comparison of subcellular distribution of mevalonate pyrophosphate decarboxylase between stroke-prone spontaneously hypertensive rat and Wistar Kyoto rat. , 2002, Biological & pharmaceutical bulletin.

[2]  Y. Yamori,et al.  Mevalonate pyrophosphate decarboxylase in stroke-prone spontaneously hypertensive rat is reduced from the age of two weeks. , 2001, Biological & pharmaceutical bulletin.

[3]  M. Kitagawa,et al.  Geranylgeranylpyrophosphate, a metabolite of mevalonate, regulates the cell cycle progression and DNA synthesis in human lymphocytes. , 1997, Biochemical and biophysical research communications.

[4]  R. Reddel,et al.  Malignant transformation of NIH3T3 cells by overexpression of mot-2 protei , 1998, Oncogene.

[5]  S. Kaul,et al.  Elevated levels of mortalin expression in human brain tumors. , 1997, Experimental cell research.

[6]  R. Hohl.  Monoterpenes as regulators of malignant cell proliferation. , 1996, Advances in experimental medicine and biology.

[7]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[8]  O. Pereira-smith,et al.  Mortalin: present and prospective , 2002, Experimental Gerontology.

[9]  S. Kaul,et al.  Induction of cellular senescence by transfection of cytosolic mortalin cDNA in NIH 3T3 cells. , 1993, The Journal of biological chemistry.

[10]  M. McMahon,et al.  Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. , 1999, American journal of respiratory cell and molecular biology.

[11]  F. McCormick.  Ras‐related proteins in signal transduction and growth control , 1995, Molecular reproduction and development.

[12]  Y. Yamori,et al.  Lower mevalonate pyrophosphate decarboxylase activity is caused by the reduced amount of enzyme in stroke-prone spontaneously hypertensive rat. , 1998, Journal of biochemistry.

[13]  F. Dautry,et al.  Mevalonate deprivation alters the induction of fos and myc by growth factors. , 1990, Oncogene.

[14]  Y. Yamori,et al.  Difference in subcellular distribution between 45- and 37-kDa mevalonate pyrophosphate decarboxylase in rat liver. , 2001, Biological & pharmaceutical bulletin.

[15]  M. Crouzet,et al.  Stable DNA-binding yeast vector allowing high-bait expression for use in the two-hybrid system. , 1997, BioTechniques.

[16]  J. R. Smith,et al.  Extramitochondrial localization of mortalin/mthsp70/PBP74/GRP75. , 2000, Biochemical and biophysical research communications.

[17]  S. Kaul,et al.  Expression analysis of mortalin, a unique member of the Hsp70 family of proteins, in rat tissues. , 1997, Experimental cell research.

[18]  S. Kaul,et al.  Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. , 1993, The Journal of biological chemistry.

[19]  S. Mizutani,et al.  Unfarnesylated transforming Ras mutant inhibits the Ras‐signaling pathway by forming a stable Ras·Raf complex in the cytosol , 1996, FEBS letters.

[20]  D. Gomez,et al.  Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis , 1998, Breast Cancer Research and Treatment.

[21]  M. Serrano.  The tumor suppressor protein p16INK4a. , 1997, Experimental cell research.

[22]  Y. Yamori,et al.  Purification and characterization of two mevalonate pyrophosphate decarboxylases from rat liver: a novel molecular species of 37 kDa. , 1997, Journal of biochemistry.

[23]  V. Ferrans,et al.  Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species* , 1999, The Journal of Biological Chemistry.

[24]  R. Reddel,et al.  Structurally and functionally distinct mouse hsp70 family members Mot-1 and Mot-2 proteins are encoded by two alleles. , 2000, DNA research : an international journal for rapid publication of reports on genes and genomes.

[25]  B. Kasiske,et al.  Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? , 1996, The Lancet.

[26]  S. Lowe,et al.  Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.

[27]  S. Kaul,et al.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? , 2002, Cell stress & chaperones.

[28]  M. McMahon,et al.  Raf‐1‐induced cell cycle arrest in LNCaP human prostate cancer cells , 1999, Journal of cellular biochemistry.

[29]  E. Merler,et al.  Inhibition of growth factor signaling pathways by lovastatin. , 1991, Biochemical and biophysical research communications.

[30]  R. Reddel,et al.  Inactivation of p53 and life span extension of human diploid fibroblasts by mot‐2 , 2000 .

[31]  Y. Yamori,et al.  Mevalonate pyrophosphate decarboxylase is predominantly located in the cytosol of rat hepatocytes. , 2001, Biological & pharmaceutical bulletin.

[32]  S. Baylin,et al.  Activated Raf-1 causes growth arrest in human small cell lung cancer cells. , 1998, The Journal of clinical investigation.

[33]  R. Reddel,et al.  Inactivation of Tumor Suppressor p53 by Mot-2, a hsp70 Family Member* , 1998, The Journal of Biological Chemistry.

[34]  M. McMahon,et al.  Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 , 1997, Oncogene.